The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
The combination of drugs for hypertension and software to personalise dosing to an individual patient has been shown to deliver improved blood pressure control and adherence to therapy in a pilot ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback